Iniciar sesión
Registrarse
Restablecer contraseña
Publicar y Distribuir
Soluciones de Publicación
Soluciones de Distribución
Temas
Arquitectura y diseño
Artes
Ciencias Sociales
Ciencias de la Información y Bibliotecas, Estudios del Libro
Ciencias de la vida
Ciencias de los materiales
Deporte y tiempo libre
Estudios clásicos y del Cercano Oriente antiguo
Estudios culturales
Estudios judíos
Farmacia
Filosofía
Física
Geociencias
Historia
Informática
Ingeniería
Interés general
Ley
Lingüística y semiótica
Literatura
Matemáticas
Medicina
Música
Negocios y Economía
Química
Química industrial
Teología y religión
Publicaciones
Revistas
Libros
Actas
Editoriales
Blog
Contacto
Buscar
EUR
USD
GBP
Español
English
Deutsch
Polski
Español
Français
Italiano
Carrito
Home
Revistas
Polish Journal of Microbiology
Volumen 71 (2022): Edición 2 (June 2022)
Acceso abierto
Oral Microbiota, a Potential Determinant for the Treatment Efficacy of Gastric
Helicobacter pylori
Eradication in Humans
Huixia Chen
Huixia Chen
,
Hui Xie
Hui Xie
,
Dong Shao
Dong Shao
,
Liju Chen
Liju Chen
,
Siyu Chen
Siyu Chen
,
Lin Wang
Lin Wang
y
Xiao Han
Xiao Han
| 31 may 2022
Polish Journal of Microbiology
Volumen 71 (2022): Edición 2 (June 2022)
Acerca de este artículo
Artículo anterior
Artículo siguiente
Resumen
Artículo
Figuras y tablas
Referencias
Materiales relacionados
Autores
Artículos en este número
Vista previa
PDF
Cite
Compartir
Article Category:
Original Paper
Publicado en línea:
31 may 2022
Páginas:
227 - 239
Recibido:
05 ene 2022
Aceptado:
22 mar 2022
DOI:
https://doi.org/10.33073/pjm-2022-020
Palabras clave
eradication
,
therapeutic effects
,
oral microbiota
,
sequencing
© 2022 Huixia Chen et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1
Sample collection and qualification of 16S rRNA sequencing.A) A schematic diagram illustrating the sample collection process; B) rarefaction curve analysis; C) specaccum curve analyses; D) rank abundance analysis; n = 7 for the SE group, n = 9 for the FE group; FE – failure eradication, SE – successful eradication, HP – Helicobacter pylori.
Fig. 2
α and β Diversity analyses.A) Observed species, Chao1 richness, ACE index, Shannon index, Simpson index, and J index were calculated for α diversity of the oral microbiota.
Fig. 2
α and β Diversity analyses.B) PCoA analysis for β diversity of the oral microbiota; SE – patients with successful eradication therapy, FE – patients with failed eradication therapy.
Fig. 3
Component analysis of community structure.A) Relative abundances of the ten most abundant bacterial phyla in the FE and SE groups; B) relative abundances of the indicated individuals’ ten most abundant bacterial phyla; C) t-test analysis comparing oral microbiota composition between the FE and SE groups.
Fig. 3
Component analysis of community structure.D) cladogram generated from LEfSe analysis.
Fig. 3
Component analysis of community structure.E) LDA scores of significantly altered taxa presented in panel D; n = 7 for the SE group, n = 9 for the FE group; SE – patients with successful eradication therapy, FE – patients with failed eradication therapy.
Fig. 4
Correlation analysis of microbial environmental factors.A) RDA analysis comparing OTUs between the FE and SE groups.
Fig. 4
Correlation analysis of microbial environmental factors.E) KEGG analysis diagram; n = 7 for the SE group, n = 9 for the FE group; SE – patients with successful eradication therapy, FE – patients with failed eradication therapy.
Fig. 4
Correlation analysis of microbial environmental factors.B) heat map analysis based on RDA analysis showing the abundance of 14 OTUs influenced by Helicobacter pylori infection.
Fig. 4
Correlation analysis of microbial environmental factors.C) correlations of the abundances of 14 OTUs with DOB values, ages, sex, and treatment status in patients from either FE or SE groups;*p < 0.05, **p < 0.01; PICRUSt2 function prediction of changed OTUs; D) PCA analysis.
Fig. 5
Venn analysis revealing differently affected and overlapping OTUs between the FE and SE groups; n = 7 for the SE group, n = 9 for the FE group; SE – patients with successful eradication therapy, FE – patients with failed eradication therapy.
Vista previa